Camrelizumab combined with microwave ablation improves the objective response rate in advanced non-small cell lung cancer

Conclusions: Camrelizumab administration combined with MWA was safe in the treatment of advanced NSCLC, and the combination improved the ORR of camrelizumab alone compared to previous reports.

Source: Journal of Cancer Research and Therapeutics - January 12, 2020 Category: Cancer & Oncology Authors: Zhigang Wei Xia Yang Xin Ye Guanghui Huang Wenhong Li Xiaoying Han Jiao Wang Min Meng Yang Ni Zhigeng Zou Qiang Wen Source Type: research